These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10381366)

  • 1. Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38) by the human UDP-glucuronosyltransferases encoded at the UGT1 locus.
    Ciotti M; Basu N; Brangi M; Owens IS
    Biochem Biophys Res Commun; 1999 Jun; 260(1):199-202. PubMed ID: 10381366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38).
    Gagné JF; Montminy V; Belanger P; Journault K; Gaucher G; Guillemette C
    Mol Pharmacol; 2002 Sep; 62(3):608-17. PubMed ID: 12181437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D.
    Jinno H; Tanaka-Kagawa T; Hanioka N; Saeki M; Ishida S; Nishimura T; Ando M; Saito Y; Ozawa S; Sawada J
    Drug Metab Dispos; 2003 Jan; 31(1):108-13. PubMed ID: 12485959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel functional polymorphisms in the UGT1A7 and UGT1A9 glucuronidating enzymes in Caucasian and African-American subjects and their impact on the metabolism of 7-ethyl-10-hydroxycamptothecin and flavopiridol anticancer drugs.
    Villeneuve L; Girard H; Fortier LC; Gagné JF; Guillemette C
    J Pharmacol Exp Ther; 2003 Oct; 307(1):117-28. PubMed ID: 12944498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of human UDP-glucuronosyltransferase 1A9 variant, D256N, found in Japanese cancer patients.
    Jinno H; Saeki M; Saito Y; Tanaka-Kagawa T; Hanioka N; Sai K; Kaniwa N; Ando M; Shirao K; Minami H; Ohtsu A; Yoshida T; Saijo N; Ozawa S; Sawada J
    J Pharmacol Exp Ther; 2003 Aug; 306(2):688-93. PubMed ID: 12730278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of common genetic variants of human uridine diphosphate glucuronosyltransferase subfamilies on irinotecan glucuronidation.
    Tagawa K; Maruo Y; Mimura Y; Ikushiro S
    Toxicol Mech Methods; 2023 Mar; 33(3):197-205. PubMed ID: 35930428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.
    Iyer L; King CD; Whitington PF; Green MD; Roy SK; Tephly TR; Coffman BL; Ratain MJ
    J Clin Invest; 1998 Feb; 101(4):847-54. PubMed ID: 9466980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A humanized UGT1 mouse model expressing the UGT1A1*28 allele for assessing drug clearance by UGT1A1-dependent glucuronidation.
    Cai H; Nguyen N; Peterkin V; Yang YS; Hotz K; La Placa DB; Chen S; Tukey RH; Stevens JC
    Drug Metab Dispos; 2010 May; 38(5):879-86. PubMed ID: 20124398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UGT1A10 is responsible for SN-38 glucuronidation and its expression in human lung cancers.
    Oguri T; Takahashi T; Miyazaki M; Isobe T; Kohno N; Mackenzie PI; Fujiwara Y
    Anticancer Res; 2004; 24(5A):2893-6. PubMed ID: 15517893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel UGT1A9 intronic I399 polymorphism appears as a predictor of 7-ethyl-10-hydroxycamptothecin glucuronidation levels in the liver.
    Girard H; Villeneuve L; Court MH; Fortier LC; Caron P; Hao Q; von Moltke LL; Greenblatt DJ; Guillemette C
    Drug Metab Dispos; 2006 Jul; 34(7):1220-8. PubMed ID: 16595709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of the function of the UDP-glucuronosyltransferase 1A subfamily by cytochrome P450 3A4: different susceptibility for UGT isoforms and UGT1A1/7 variants.
    Ishii Y; Koba H; Kinoshita K; Oizaki T; Iwamoto Y; Takeda S; Miyauchi Y; Nishimura Y; Egoshi N; Taura F; Morimoto S; Ikushiro S; Nagata K; Yamazoe Y; Mackenzie PI; Yamada H
    Drug Metab Dispos; 2014 Feb; 42(2):229-38. PubMed ID: 24255116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinally distributed UDP-glucuronosyltransferase 1A10, which metabolizes estrogens and nonsteroidal anti-inflammatory drugs, depends upon phosphorylation.
    Basu NK; Kubota S; Meselhy MR; Ciotti M; Chowdhury B; Hartori M; Owens IS
    J Biol Chem; 2004 Jul; 279(27):28320-9. PubMed ID: 15117964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Close association of UGT1A9 IVS1+399C>T with UGT1A1*28, *6, or *60 haplotype and its apparent influence on 7-ethyl-10-hydroxycamptothecin (SN-38) glucuronidation in Japanese.
    Saito Y; Sai K; Maekawa K; Kaniwa N; Shirao K; Hamaguchi T; Yamamoto N; Kunitoh H; Ohe Y; Yamada Y; Tamura T; Yoshida T; Minami H; Ohtsu A; Matsumura Y; Saijo N; Sawada J
    Drug Metab Dispos; 2009 Feb; 37(2):272-6. PubMed ID: 18981166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal glucuronidation protects against chemotherapy-induced toxicity by irinotecan (CPT-11).
    Chen S; Yueh MF; Bigo C; Barbier O; Wang K; Karin M; Nguyen N; Tukey RH
    Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19143-8. PubMed ID: 24191041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of obesity on accumulation of the toxic irinotecan metabolite, SN-38, in mice.
    Mallick P; Shah P; Gandhi A; Ghose R
    Life Sci; 2015 Oct; 139():132-8. PubMed ID: 26334566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism.
    Iyer L; Hall D; Das S; Mortell MA; Ramírez J; Kim S; Di Rienzo A; Ratain MJ
    Clin Pharmacol Ther; 1999 May; 65(5):576-82. PubMed ID: 10340924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A1 enzymes.
    Hanioka N; Tanabe N; Jinno H; Tanaka-Kagawa T; Nagaoka K; Naito S; Koeda A; Narimatsu S
    Life Sci; 2010 Aug; 87(7-8):261-8. PubMed ID: 20620155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of intestinal UDP-glucuronosyltransferases in modulating 7-ethyl-10-hydroxy-camptothecin (SN-38)-induced gastrointestinal toxicity in rats.
    Tallman MN; Miles KK; Kessler FK; Nielsen JN; Tian X; Ritter JK; Smith PC
    J Pharmacol Exp Ther; 2007 Jan; 320(1):29-37. PubMed ID: 17003228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation and function of family 1 and family 2 UDP-glucuronosyltransferase genes (UGT1A, UGT2B) in human oesophagus.
    Strassburg CP; Strassburg A; Nguyen N; Li Q; Manns MP; Tukey RH
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):489-98. PubMed ID: 10024527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UGT1A1*28 genotype affects the in-vitro glucuronidation of thyroxine in human livers.
    Yoder Graber AL; Ramírez J; Innocenti F; Ratain MJ
    Pharmacogenet Genomics; 2007 Aug; 17(8):619-27. PubMed ID: 17622938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.